Literature DB >> 18312860

The fork in the nitric oxide road: cyclic GMP or nitrosylation?

Mark T Ziolo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18312860      PMCID： PMC2366797          DOI： 10.1016/j.niox.2008.01.008

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN： 1089-8603            Impact factor:   4.427


× No keyword cloud information.
  36 in total

1.  Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation.

Authors:  L Xu; J P Eu; G Meissner; J S Stamler
Journal:  Science       Date:  1998-01-09       Impact factor: 47.728

2.  Mechanical transduction of nitric oxide synthesis in the beating heart.

Authors:  D J Pinsky; S Patton; S Mesaros; V Brovkovych; E Kubaszewski; S Grunfeld; T Malinski
Journal:  Circ Res       Date:  1997-09       Impact factor: 17.367

3.  Potentiation by cyclic GMP of beta-adrenergic effect on Ca2+ current in guinea-pig ventricular cells.

Authors:  K Ono; W Trautwein
Journal:  J Physiol       Date:  1991-11       Impact factor: 5.182

4.  Heterogeneous basal expression of nitric oxide synthase and superoxide dismutase isoforms in mammalian heart : implications for mechanisms governing indirect and direct nitric oxide-related effects.

Authors:  M V Brahmajothi; D L Campbell
Journal:  Circ Res       Date:  1999-10-01       Impact factor: 17.367

5.  Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols.

Authors:  D L Campbell; J S Stamler; H C Strauss
Journal:  J Gen Physiol       Date:  1996-10       Impact factor: 4.086

6.  Positive and negative inotropic effects of NO donors in atrial and ventricular fibres of the frog heart.

Authors:  J M Chesnais; R Fischmeister; P F Méry
Journal:  J Physiol       Date:  1999-07-15       Impact factor: 5.182

7.  Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes.

Authors:  M G Vila-Petroff; A Younes; J Egan; E G Lakatta; S J Sollott
Journal:  Circ Res       Date:  1999-05-14       Impact factor: 17.367

8.  Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat.

Authors:  Jennifer K Bendall; Thibaud Damy; Philippe Ratajczak; Xavier Loyer; Virginie Monceau; Isabelle Marty; Paul Milliez; Estelle Robidel; Françoise Marotte; Jane-Lise Samuel; Christophe Heymes
Journal:  Circulation       Date:  2004-10-04       Impact factor: 29.690

9.  Low increase in cGMP induced by organic nitrates and nitrovasodilators improves contractile response of rat ventricular myocytes.

Authors:  G Kojda; K Kottenberg; P Nix; K D Schlüter; H M Piper; E Noack
Journal:  Circ Res       Date:  1996-01       Impact factor: 17.367

10.  Myocyte nitric oxide synthase 2 contributes to blunted beta-adrenergic response in failing human hearts by decreasing Ca2+ transients.

Authors:  Mark T Ziolo; Lars S Maier; Valentino Piacentino; Julie Bossuyt; Steven R Houser; Donald M Bers
Journal:  Circulation       Date:  2004-03-22       Impact factor: 29.690
View more
  16 in total

1.  Regulation of myocyte contraction via neuronal nitric oxide synthase: role of ryanodine receptor S-nitrosylation.

Authors:  Honglan Wang; Serge Viatchenko-Karpinski; Junhui Sun; Inna Györke; Nancy A Benkusky; Mark J Kohr; Héctor H Valdivia; Elizabeth Murphy; Sandor Györke; Mark T Ziolo
Journal:  J Physiol       Date:  2010-06-07       Impact factor: 5.182

2.  Attenuated response of L-type calcium current to nitric oxide in atrial fibrillation.

Authors:  Nadiia Rozmaritsa; Torsten Christ; David R Van Wagoner; Hannelore Haase; Johannes-Peter Stasch; Klaus Matschke; Ursula Ravens
Journal:  Cardiovasc Res       Date:  2013-12-12       Impact factor: 10.787

3.  Characterization of potential S-nitrosylation sites in the myocardium.

Authors:  Mark J Kohr; Angel M Aponte; Junhui Sun; Guanghui Wang; Elizabeth Murphy; Marjan Gucek; Charles Steenbergen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-01-28       Impact factor: 4.733

4.  Moving into a new neighborhood: NOS goes nuclear.

Authors:  Mark T Ziolo; Brandon J Biesiadecki
Journal:  J Mol Cell Cardiol       Date:  2013-06-22       Impact factor: 5.000

Review 5.  Abnormal Ca(2+) cycling in failing ventricular myocytes: role of NOS1-mediated nitroso-redox balance.

Authors:  Mark T Ziolo; Steven R Houser
Journal:  Antioxid Redox Signal       Date:  2014-08-07       Impact factor: 8.401

6.  Hypotonic swelling promotes nitric oxide release in cardiac ventricular myocytes: impact on swelling-induced negative inotropic effect.

Authors:  Luis Alberto Gonano; Malena Morell; Juan Ignacio Burgos; Raul Ariel Dulce; Verónica Celeste De Giusti; Ernesto Alejandro Aiello; Joshua Michael Hare; Martin Vila Petroff
Journal:  Cardiovasc Res       Date:  2014-10-24       Impact factor: 10.787

7.  Displacement-encoded and manganese-enhanced cardiac MRI reveal that nNOS, not eNOS, plays a dominant role in modulating contraction and calcium influx in the mammalian heart.

Authors:  Moriel H Vandsburger; Brent A French; Christopher M Kramer; Xiaodong Zhong; Frederick H Epstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

8.  Antagonism of soluble guanylyl cyclase attenuates cutaneous vasodilation during whole body heat stress and local warming in humans.

Authors:  Dean L Kellogg; Joan L Zhao; Yubo Wu; John M Johnson
Journal:  J Appl Physiol (1985)       Date:  2011-02-03

9.  Neuronal nitric oxide synthase signaling within cardiac myocytes targets phospholamban.

Authors:  Honglan Wang; Mark J Kohr; Christopher J Traynham; Debra G Wheeler; Paul M L Janssen; Mark T Ziolo
Journal:  Am J Physiol Cell Physiol       Date:  2008-04-09       Impact factor: 4.249

10.  Phosphodiesterase 5 restricts NOS3/Soluble guanylate cyclase signaling to L-type Ca2+ current in cardiac myocytes.

Authors:  Honglan Wang; Mark J Kohr; Christopher J Traynham; Mark T Ziolo
Journal:  J Mol Cell Cardiol       Date:  2009-04-01       Impact factor: 5.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.